Jim Simons’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Jim Simons’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-806,763	Closed	-$1.94M	–	3776
2018 Q4	$1.94M	Buy	806,763 +710,847	+741%	+$2.32M	﹤0.01%	2252
2018 Q3	$422K	Sell	95,916 -255,347	-73%	-$1.42M	﹤0.01%	2908
2018 Q2	$2.53M	Sell	351,263 -545,900	-61%	-$3.71M	﹤0.01%	2152
2018 Q1	$4.62M	Buy	+897,163	New	+$6.38M	0.01%	1864
2017 Q4	–	Sell	-233,563	Closed	-$397K	–	3551
2017 Q3	$397K	Buy	233,563 +171,800	+278%	+$315K	﹤0.01%	2844
2017 Q2	$124K	Buy	+61,763	New	+$121K	﹤0.01%	3065
2016 Q2	–	Sell	-53,890	Closed	-$290K	–	3561
2016 Q1	$290K	Buy	53,890 +24,700	+85%	+$144K	﹤0.01%	2988
2015 Q4	$254K	Buy	+29,190	New	+$246K	﹤0.01%	2932
2015 Q3	–	Sell	-57,547	Closed	-$1.01M	–	3425
2015 Q2	$1.01M	Buy	+57,547	New	+$739K	﹤0.01%	2444

Other funds holding SRNE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Jim Simons's SRNE Position: Q1 2019 in Review

Jim Simons sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2019, closing a stake of 806,763 shares — an estimated $1.94M sold.

Jim Simons first reported a position in SRNE in Q2 2015 and held it in 9 quarters. The position peaked at $4.62M in Q1 2018. 84 funds tracked by Wall St. Rank hold SRNE as of Q1 2019.

Jim Simons reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
Jim Simons sold 806,763 Sorrento Therapeutics, Inc. shares in Q1 2019, an estimated $1.94M.
Jim Simons first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 9 quarters.
Jim Simons's Sorrento Therapeutics, Inc. position peaked at $4.62M in Q1 2018.
84 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2019.

Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.